Wall Street is closing out a strong quarter. Plus, Lilly's mixed obesity drug trial data
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
3 days ago CNBC – Top News
535 stories found
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
Options volume was more than 50% above the 30-day average in both names Wednesday.
It is unclear how long the recovery can be sustained given that it relies on U.S. military protecting tankers in the Persian Gulf.
The Wall Street Journal reported MGM was exploring an offer for People Inc. after People Inc. withdrew its $48.30-per-share proposal to buy the rest of MGM.
The higher odds come after the artificial intelligence company reportedly warned investors in its IPO prospectus that its models could be dangerous.
Commerce Secretary Howard Lutnick unwound his ties to Cantor Fitzgerald as the billionaire financier joined the Trump administration.
The refunds come after millions of people lost premium subsidies for their health insurance, and right before the midterm elections.
The Trump administration announced on Wednesday that it was launching a "Default Loans Support Center" for student loan borrowers who've fallen behind.
The probe adds to the mounting scrutiny that OpenAI and Anthropic have been facing over their safety practices following the Hugging Face hack.
Investors should be more selective when interest rates are on the rise. That doesn't mean leave the market all together.
The Senate will vote on bills that would ban members from trading stocks while in office, and to address data center-related utility costs, amid Democratic opposition.
With AI spending consuming the cash of the market's richest companies, balance sheet metrics led by free cash flow are getting more investing attention.
Stellantis CEO Antonio Filosa on Wednesday reconfirmed the company's 2026 guidance and its plans to be cash-flow positive by 2027.
Some well-meaning career advice from parents is "totally useless" for new grads today, according to journalist Jodi Kantor.
Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.
Unusual trading patterns on Kalshi and Polymarket are drawing scrutiny as experts debate whether reported volumes reflect organic market activity.
The Trump administration says the tariffs respond to countries failing to effectively ban the trade of goods produced using forced-labor practices.
A media report this week said President Donald Trump stated that Clayton, the director of national intelligence, would make a good AI czar.
Both stocks have pulled back this month, but our reasons for owning them have not changed.